Ligne de temps
Lhousseine Touqui
Chef(fe) de Groupe
14 juin 2022
publication
Human peroxiredoxin 6 is essential for malaria parasites and provides a host-based drug target.
Lire plus23 févr. 2022
project
Role of inflammatory mediators as predicting factors of COVID-19 pulmonary disease
Lire plus15 mai 2019
event
Cancelled (will be postponed) – Global Health Department Seminar “Molecular insights into host-pathogen reveals potential new therapeutic targets for MRSA and streptococci”
Lire plus02 juin 2018
01 mars 2018
event
“Immunomodulatory antimicrobial peptides: biology and applications” Infection & Epidemiology department seminar
Lire plus17 nov. 2017
publication
High-Density Lipoproteins Exert Pro-inflammatory Effects on Macrophages via Passive Cholesterol Depletion and PKC-NF-κB/STAT1-IRF1 Signaling
Lire plus18 juil. 2016
04 juil. 2016
22 avr. 2015
publication
Staphylococcus aureus Adenosine Inhibits sPLA2-IIA-Mediated Host Killing in the Airways
Lire plus01 mars 2015
publication
Host-microbe interactions in distal airways: relevance to chronic airway diseases
Lire plus27 nov. 2014
publication
Cystic fibrosis bone disease: is the CFTR corrector C18 an option for therapy?
Lire plus07 oct. 2014
publication
Pseudomonas aeruginosa eradicates Staphylococcus aureus by manipulating the host immunity
Lire plus06 sept. 2014
publication
Cytosolic phospholipase A2α enhances mouse mortality induced by Pseudomonas aeruginosa pulmonary infection via interleukin 6
Lire plus15 mars 2014
publication
Cystic fibrosis and bone disease: defective osteoblast maturation with the F508del mutation in cystic fibrosis transmembrane conductance regulator
Lire plus04 mars 2014
publication
ZapE is a novel cell division protein interacting with FtsZ and modulating the Z-ring dynamics
Lire plus04 mars 2014
publication
Toll-like receptor 9 deficiency protects mice against Pseudomonas aeruginosa lung infection
Lire plus30 juil. 2013
publication
Secreted group IIA phospholipase A2 protects humans against the group B streptococcus: experimental and clinical evidence
Lire plus21 mars 2013
publication
CFTR dysfunction induces vascular endothelial growth factor synthesis in airway epithelium
Lire plus02 juil. 2012
publication
A crucial role of Flagellin in the induction of airway mucus production by Pseudomonas aeruginosa
Lire plus01 juil. 2012
publication
Antisense inhibition of phospholipase A2: a new approach for already tested therapeutic targets for the treatment of sepsis*
Lire plus22 mars 2012
publication
A role for 12R-lipoxygenase in MUC5AC expression by respiratory epithelial cells
Lire plus01 mars 2012
publication
Influenza A induces the major secreted airway mucin MUC5AC in a protease-EGFR-extracellular regulated kinase-Sp1-dependent pathway
Lire plus09 nov. 2011
publication
A novel bacterial resistance mechanism against human group IIA-secreted phospholipase A2: role of Streptococcus pyogenes sortase A
Lire plus29 avr. 2010
publication
Cytosolic phospholipase A2alpha mediates Pseudomonas aeruginosa LPS-induced airway constriction of CFTR -/- mice
Lire plus01 déc. 2003
publication
Interaction of secreted phospholipase A2 and pulmonary surfactant and its pathophysiological relevance in acute respiratory distress syndrome
Lire plus01 juin 2003
publication
Induction of type-IIA secretory phospholipase A2 in animal models of acute lung injury
Lire plus01 avr. 2002
publication
Arachidonic acid differentially affects basal and lipopolysaccharide-induced sPLA(2)-IIA expression in alveolar macrophages through NF-kappaB and PPAR-gamma-dependent pathways
Lire plus01 avr. 2002
publication